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PRELIMINARY AND SHORT REPORTS
EFFECTS OF TOPICAL CORTISONE ON CHRONIC DISCOID LUPUS
ERYTHEMATOSUS AND NECROBIOSIS LIPOIDICA
DIABETICORUM*
BEN A. NEWMAN, M.D. AND FRED F. FELDMAN, M.D.
The recent favorable results achieved by ophthalmologists in the treatment of ocular
inflammatory disease with local instillation of cortisone suggested to us that regressive
changes in certain dermatosos might follow topically applied cortisone. We felt that patients
with chronic discoid lupus erythematosus and necrobiosis lipoidica diabeticorum would be
appropriate for this study because both dermatoses present vascular and collagen dis-
turbances, and both are notoriously resistant to treatment. Since involution to some
degree has been observed in all our patients studied, a preliminary report appears warranted
Material
Ten patients with chronic discoid lupus erythematosus and three patients with necrobi-
osis lipoidicn diaheticorum were treated with cortisone ointment. It was applied to the
involved sites 3 to 4 times daily. The concentrations of cortisone used were 3.3mg, 5mg and
25mg per gram of ointment base. After the first month of this study Carbowax was substi-
tuted for Neobase (R) as a vehicle. Five of these patients were presented at a meeting of
the Los Angeles Dermatological Society on January 9, 1951. In no patient was any other
type of medication given during the period cortisone was applied.
Results
One representative patient of each dermatosis is described. Case I. E. Y., a 39 year old
Japanese male was first seen by us on June 17, 1950. He presented erythematous annular
and oval-shaped lesions on his face, neck and upper back. Some of these areas showed
adherent scaling and telangiectasia, and a few patches showed evidence of atrophy. The
clinical diagnosis was typical chronic discoid lupus erythematosus. The eruption started
on the nose in 1945 and later spread to the cheeks, forehead, neck, ears and upper back. A
complete medical study including laboratory work in May 1950 revealed no abnormalities.
From June 17, 1950 to September 11, 1950, he received Bistrimate, crude liver extract, in-
jections of bismuth subsalicylate, applications of CO2 ice, and tocopherols orally. There
was partial improvement in some of the lesions, but most of the lesions showed progression.
Cortisone Treatment: On September 11, 1950, he was given an ointment containing 3.3
mg cortisone per gram neobnse(R) and he was instructed to massage the ointment intn the
affected areas three times daily.
By October 13, 1950, there was about 50 per cent improvement. The lesions were becoming
pigmented and were undergoing involution. By October 21, 1950, the lesions of his back
had healed without pigmentation, and the lesions on his cheeks had healed with pigmen-
tation. Those below his left eye showed about 75 per cent involution and were partially
pigmented. Lesions in the left retroauriculnr region began to show evidence of healing for
the first time. By October 28, 1950, the lesions below the eyes were practically healed and
there was only slight erythema remaining in the involved areas in the left retroauricular
region. By December 2, 1950, 95 per cent improvement was shown. On January 9, 1951, he
was presented at the meeting of the Los Angeles Dermatological Society, with almost
complete involution of the lesions. Some of the areas showed complete healing without
pigmentation, others showed increased pigmentation and a few spots were atrophic.
* From the Depts. of Dermatology, Cedars of Lebanon and Los Angeles County General
Hospitals.
Cortisone in carbowax was supplied by Merck & Co. for this study.
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Case II, Y. C., a 24 year old housewife has had diabetes mellitus for the past 12 years
and has taken insulin daily during this period. She noted the onset of a red patch on her
left lower leg about 5 years ago, which gradually became larger. About 6 months ago the
lesion became ulcerated and she was given Terramycin, which had no effect npon the
healing of the ulcer. The patient presented a lesion S cm long and 3 cm wide, with an L
shaped extension at the lower pole. The borders of the lesion were violaceons and the center
was a yellowish-orange color, and contained telangiectatic vessels. At the superior and
inferior poles of the lesion there were small coin size, superficial ulcers covered with a thick
crust. A biopsy confirmed the clinical diagnosis of necrobiosis lipoidica diabeticorum.
Cortisone Treetrnent: During the first week of November 1950, cortisone ointment (3.3
mg/gm Neobase) was prescribed, and she was instructed to massage this cream into the
lesion four times daily. The first change noted was a dramatic healing of the ulceration by
the fifth day. It was then noted that the redness and the yellow-orange color of the lesion
was beginning to fade for the first time in five years. On December 5, 1950, a more concen-
trated ointment was substituted (25 mg cortisone per gm Carbowax). During the next two
weeks a more pronounced involution was noted.
On January 9, 1951, she was presented at the monthly meeting of the Los Angeles Derma-
tological Society. At this time the lesion was smaller in area, there was a reduction of the
thickness of the lesion so that the skin conld be grasped between the fingers and wrinkling
observed. The ulcerated areas showed cribriform scars, and the previous violaceous and
yellow-orange color had changed to a light pink center with dusky pigmentation at the
periphery.
The entire group of thirteen patients studied is tabulated below. Some degree of im-
provement was noted in all. The degree of improvement will he designated as slight (10—
50%), moderate (50—75%) and marked 75—95%).
TABLE I
Chronic discoid lap us erythematosus
NUll- wEERS DEGREE OF
BEE INITIALS AGE SEX LOCATION DURATION SEVERITY CONCENTRATION TREAT- IMPROVE-
MENT MENT
yrs. me/em
1 K. L. 73 F Face 10 marked 3.3 and 5 6 marked
2 M. H. 35 F Face 10 moderate 5 and 25 15 moderate
3 N. H. 52 F Face, neck 1+ moderate 5 and 25 15 slight
and arms
4 D. M. 45 F Face 5 marked 3.3 and 25 10 moderate
5 A. M. 41 F Face 2(?) mild 5 4 slight
6 A. B. 29 F Face and 6 me. marked 25 1 moderate
scalp
7 E. Y. 39 M Face, neck 5 marked 3.3 and 5 17 marked
and back
S A. W. 44 F Face 4 marked 25 4 moderate
9 A. K. 23 F Face 3 marked 3.3 and 25 11 moderate
10 H. D. 30 F Face 3 moderate 3.3 and 25 10 moderate
1
Necrobiosis Lipoidica Diabeticorurn
M. G. 40 M Left lower leg 5 marked 25 7 moderate
single patch
2 Y. C. 24 F Left lowerleg
single patch
5 marked 25 11 marked
3 L. B. 42 F Both lower 2 moderate 5 2 slight
legs
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Two patients (K. L. and E. Y.) with discoid lupus erythematosus have shown almost
complete involution of their lesions during treatment with topical cortisone. The remaining
eight patients of this group have shown involution of their eruption ranging from 10%
to 75%. In no patient was there an untoward reaction either locally or systemically during
this short period of observation nor was there any alteration in the blood chemistry. In
some patients maximum improvement occurred during the first few weeks of treatment with
only slight change in succeeding weeks. The tumid type of lesion appeared to respond better
to topical cortisone than did the hyperkeratotic type. In the majority of patients maximal
improvement did not occur until the concentration of cortisone was increased from 5 mg
to 25 mg per gram of ointment base. The first change noticed after use of topical cortisone
is a paling, followed by a reduction in the thickness of the lesions. In some patients lesions
healed with pigmentation.
In the group of necrobiosis lipoidica diabeticorum studied, both Y. C. and M. C. have
shown approximately 90% improvement since the onset of treatment with topical eorti
sone. L. B. the latest patient to enter our study, although improving, cannot as yet be
properly evaluated. In the latter group, as in our cases of lupus erythematosus, paling of
the lesions was the first change noted followed by a gradual decrease in the thickness of the
lesion.
DISCUSSION
We feel that no logical deductions can be drawn on the basis of our study and observa-
tions to date, except that some degree of involution has occurred in all our patients with
chronic discoid lupus erythematosus and neerobiosis lipoidica diabeticorum treated with
topical cortisone. Woods (1) was one of the first to report that cortisone instilled locally in
the conjunctival sac has a beneficial effect on external ocular inflammation. Rome and
Koff et al (2) after approximately a year's study have similarly reported excellent results in
ocular conditions following topical instillation as well as subconjunctival injection of
cortisone. Jones and Meyer (3) experimentally were able to inhibit vascularization of rabbit
cornea following alkali burns by suhconjunetival use of cortisone. Castor and Baker (4)
recently demonstrated that regressive changes in the normal skin of the rat can be produced
by local application of cortisone in alcoholic solution. They noted thinning of the epidermis,
cessation of hair growth, shrinking of sehaceous glands and reduction of dermal thickness
by loss of collagen fibers, but no effect on the elastic fibers.
Whether local cortisone acts by affecting the involved cutaneous blood vessels or acts on
the collagcnous tissue directly, or by some other mechanism remains to be shown. To date,
biopsy studies of our group of patients have not provided us with the answer. We shall
report more fully on this phase at a later date.
We feel that further investigation of topical cortisone in similar and perhaps related
dermatoses is warranted on the basis of our observations as well as those of the afore-
mentioned reports.
CONCLUSIONS
(1) Ten patients with chronic discoid lupus erythematosus and three patients with
necrobiosis lipoidica diabetieorum were treated with topical cortisone in an ointment base.
(2) Some degree of involution was noted in all the patients studied varying from minimal
to almost complete clearing.
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ADDENDUM
Since submission of this preliminary report for publication, three patients with chronic
discoid lupus erythematosus (E.Y., A.B., and K.L.) have shown complete involution of
their lesions following continued local application of cortisone. Recently, E.Y. has devel-
oped new lesions in formerly unaffected areas on the face. One patient with necrobiosis
lipoidica diabetieorum (Y.C.) has also gone on to complete healing. It is believed that if
little change is noted in lesions after local application of cortisone ointment for one month
it is unlikely that further improvement will resolt.
